Skip to main content
Equibles
RAPP logo

RAPP · Rapport Therapeutics, Inc.

Track RAPP — free

Use RAPP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RAPP

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$47.42 +0.06 (+0.13%) At close · Aug 14
Market Cap
$2.28B
Shares
47.98M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
2,256,317 +0.4% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
71/100
Short interest 4.7% of shares — P72 Days to cover 7.5 — P82 Price vs VWAP +18.3% — P90 Short-volume trend +12.0% — P87 Short interest change -16.4% — P19 Worst FTD 0.01% of shares — P42

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 2,248,235 2,690,734 -442,499 7.51
    2026-07-15 2,690,734 2,260,158 +430,576 6.13
    2026-06-30 2,260,158 2,246,097 +14,061 4.62
    2026-06-15 2,246,097 2,459,901 -213,804 7.09
    2026-05-29 2,459,901 2,417,349 +42,552 8.64
    2026-05-15 2,417,349 3,048,448 -631,099 6.93
    2026-04-30 3,048,448 3,409,588 -361,140 7.24
    2026-04-15 3,409,588 3,849,519 -439,931 14.17
    2026-03-31 3,849,519 3,711,232 +138,287 12.15
    2026-03-13 3,711,232 3,513,015 +198,217 9.11
    2026-02-27 3,513,015 3,402,222 +110,793 12.43
    2026-02-13 3,402,222 3,289,758 +112,464 13.34
    2026-01-30 3,289,758 2,870,977 +418,781 8.81
    2026-01-15 2,870,977 2,692,137 +178,840 7.97
    2025-12-31 2,692,137 2,230,607 +461,530 5.73
    2025-12-15 2,230,607 2,149,458 +81,149 6.60
    2025-11-28 2,149,458 2,002,709 +146,749 5.44
    2025-11-14 2,002,709 1,932,558 +70,151 5.27
    2025-10-31 1,932,558 2,016,786 -84,228 5.33
    2025-10-15 2,016,786 3,030,832 -1,014,046 4.69
    2025-09-30 3,030,832 3,158,524 -127,692 3.73
    2025-09-15 3,158,524 3,146,776 +11,748 1.17
    2025-08-29 3,146,776 3,023,076 +123,700 14.18
    Showing 1–23 of 23 settlements
    Key facts CIK 2012593 CUSIP 75383L102 13F (30d) 156 filings 153 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)